Theriva Biologics
Price & Volume
Stats
See more52W Range | $0.37-$2.64 |
Market Cap | $4.6M |
Shares Short | 331,552 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.22 |
News
See moreYahoo Finance • 4 days ago
Theriva™ Biologics anuncia la presentación del VCN-12, un adenovirus oncolítico de nueva generación, en el 32.º Congreso Anual de la Sociedad Europea de Terapia Génica y Celular (ESGCT)
Yahoo Finance • 4 days ago
Theriva™ Biologics Announces Presentation Describing Next Generation Oncolytic Adenovirus VCN-12 at the 32nd Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Yahoo Finance • last month
Curious about the stocks that are showing activity after the closing bell on Wednesday?
Yahoo Finance • 2 months ago
Theriva Biologics GAAP EPS of -$1.93
About
CEO | Mr. Steven A. Shallcross CPA |
CFO | Mr. Steven A. Shallcross CPA |
Address | 9605 Medical Center Drive, Rockville, MD, United States, 20850 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 20 |
